Trogenix

Edinburgh, United Kingdom

Trogenix operates as a therapeutics company.

$19.1M raised

Jan 2024

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Trogenix raised?

Trogenix has raised $19.1M in total funding. The most recent round was Seed. The last funding was announced in January 2024.

Who are Trogenix's investors?

Trogenix's investors include IQ Capital, AIN Ventures, 4BIO Capital, Brain Tumor Investment Fund, Cancer Research Horizons.

Where is Trogenix headquartered?

Trogenix is headquartered in Edinburgh, United Kingdom.

What does Trogenix do?

Trogenix operates as a therapeutics company.

What stage is Trogenix at?

Trogenix is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 1, 2024.

MLA

"Trogenix — Funding & Investors." VCBacked, January 1, 2024, https://www.vcbacked.co/company/trogenix. Accessed July 2, 2026.

APA

VCBacked. (2024). Trogenix — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/trogenix

Wikipedia (cite web)

{{cite web |title=Trogenix — Funding & Investors |url=https://www.vcbacked.co/company/trogenix |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 1, 2024.